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Background: Current guidelines recommend the use of fractional ﬂow reserve (FFR)
for guiding the decision for coronary revascularization. Recently, new parameters are
being validated for intracoronary ischemia detection.There are few data on the
intrinsic biological variability of these measurements. The objective of this study was
to evaluate the reproducibility of the different methods of intracoronary diagnosis.
Methods: We prospectively enrolled consecutive intermediate coronary lesions dur-
ing a 6-month period. In all cases we systematically obtained measurements of the
following parameters (in the same lesion using the same sequence): Pd/Pa, iFR, FFRic
(after 80 mg intracoronary adenosine) and FFRiv (after intravenous adenosine at 140
mg/kg/min). At least two measurements of each parameter were obtained separated by
a minimum interval of 3 minutes. The agreement between the measurements of each
parameter was assessed using the intra-class correlation coefﬁcient (ICC) and the
Bland-Altman method. The variability of the four parameters was estimated using the
variation coefﬁcient (VC).
Results: Fifty three lesions were included. The mean values of each parameter were:
94.2  4.8 for Pd/Pa; 88.0  8.1 for iFR; 81.3  8.3 for FFRic and 81.6  11.3 for
FFRiv. The concordance of each parameter was very good, with coefﬁcients close to 1
in all determinations and with very precise ICC conﬁdence intervals. The ICC values
were 0.95 ( 95%CI: 0.91-0.97 ) for Pd/Pa ; 0.99 ( 95%CI: 0.98-0.99 ) for iFR ; 0.97 (
95%CI: 0.96-0.98 ) for FFRic; and 0.97 (95%CI: 0.95-0.98 ) for FFRiv. The mean
difference was not different from 0 for any parameter (Student-t test for related
samples with p values < 0.05 in all cases). The Bland-Altman analyses showed a good
agreement in all cases. The CV, however, showed greater variability for FFRiv, with a
CV of 13.8% compared with 5.1%, 9.2% and 10.2% of Pd/Pa , IFR and FFRic,
respectively.
Conclusions: Our ﬁndings suggest that the reproducibility of the different methods of
functional diagnosis is excellent. Nonetheless, the variability of these parameters
should be taken into account when making treatment decisions.
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Background: Current guidelines deem percutaneous coronary intervention (PCI) of a
non-infarct related artery (n-IRA) at the time of primary PCI (pPCI). This approach is
being challenged by recent studies, which show beneﬁts of complete rather than
culprit vessel-only revascularization at the time of pPCI. However, these studies
assessed grade of stenosis in the n-IRA by visual estimate. The impact of fractional-
ﬂow reserve (FFR) measurements during n-IRA PCI has not been assessed.
Methods: COMPARE ACUTE is an ongoing prospective, randomized trial carried
out at 14 sites across Europe and Asia. Patients were randomly allocated (2:1) to
receive either FFR guided multi-vessel (MV) PCI vs. culprit vessel-only PCI in the
setting of STEMI. The primary study endpoint is MACCE deﬁned as death,
myocardial infarction, any revascularization, or cerebral accident at 12 months. FFR
measurements were done at the discretion of the operator directly after completion of
pPCI in all n-IRA with visual estimate of 50% stenosis. Positive FFR measurement
was deﬁned as 0.80 under maximal hyperemia. Here we report analysis of the
preliminary FFR data.
Results: Since July 2011, 408 patients (613 FFR measurements) undergoing primary
PCI with multi-vessel disease were enrolled. Mean age was 60.8  13.2 (78.6% male)
with Killip class I at presentation in 96%. In 35.6% the pPCI was performed in the
LAD, 45.7% in the RCA and 18.6% in the RCX. Successful pPCI deﬁned as TIMI 3
ﬂow was achieved in 95.3%. FFR-measurements of n-IRA were performed in the
LAD in 40.2%, RCA 26.8% and RCX 33.0%. In 56.5% the FFR measurement of a n-
IRA was negative and in 43.5% positive.JACC Vol 64/11/Suppl B j September 13–17, 2014 j TCT Abstracts/FFConclusions: This preliminary data from the COMPARE ACUTE trial indicates the
high portion of negative FFR-measurements in lesions found in non-infarct related
arteries and visual estimated stenosis of >50%. This aspect should be paid regard to in
the debate on multi-vessel primary PCI in STEMI.
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Background: iFR is a new, non-hyperemic, physiologic pressure index proposed for
the assessment of intermediate coronary lesions. Recently, it has been suggested the
value of a combined approach using iFR and FFR with intravenous adenosine (FFRiv)
for the classiﬁcation of coronary lesions located within the “grey zone” of physiologic
severity. The intracoronary use of adenosine at high dose (FFRic) in combination with
iFR might facilitate the widespread clinical use of these physiologic studies, as FFRic
remains a simpler and less invasive technique that is associated with less side effects.
The objective of this study was to determine the diagnostic accuracy of a systematic
combined use of iFR and FFRic versus the classical FFRiv -used as the gold standard-
for the assessment of intermediate coronary lesions.
Methods: 38 consecutive patients with 44 intermediate coronary lesions (30-80% by
QCA) were included in the study during a 6 month-period. iFR, FFRic (600 mg ic
adenosine) and FFRiv (200 mg/kg/min) were systematically determined in all patients.
The diagnostic accuracy of the 2 tests were calculated against the reference standard of
FFRiv using a cut-off diagnostic threshold set at 0.80. The area under the curve of
each test was also analyzed.
Results: 44 lesions were included. The mean age of patients was 6611, 81% were
male and 29% were diabetics. The most frequent indication was stable angina (56%)
and the more frequent vessel was left anterior descending coronary artery (47%) and
most lesions were located at mid coronary segments (51%). The average angiographic
severity was 51% 9 and the mean FFRiv was 0.81  0.09. iFR ( optimal cut-off
value found:0,89)sensitivity (100%) was higher than FFRic (89%). However, the
speciﬁcity of iFR (70%) was less than that of FFRic (96%). Using a sequential
approach (initial determination of iFR and then FFRic for cases positive according to
iFR) an AUC of 0.98 (0.92-1) was obtained.
Conclusions: Our ﬁndings suggest that iFR as a high sensitivity whereas FFRic has a
high speciﬁcity, as compared with FFRiv. The sequential combined use of both tests
appears to be very simple, provides a very high diagnostic yield.
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Background: Coronary stenoses are stented to improve coronary ﬂow with the ma-
jority selected using angiographic anatomical parameters. We sought to quantify the
change in coronary ﬂow velocity after angiographically successful stenting and
quantify the predictive capabilities of anatomical parameters to predict ﬂow increase
after stenting and compared them to physiological indices of lesion severity.
Methods: 75 stenoses (67 patients, 629 years) selected for PCI on the basis of
anatomical ﬁndings, had hyperemic transtenotic mean coronary ﬂow velocity mea-
surements using a combined Doppler ﬂow and pressure wire, before and after stenting.
The relationship between the change in hyperemic ﬂow after stenting and both
anatomical parameters (measured by quantitative coronary angiography) and physi-
ological indices (FFR, measured during hyperemia and the instantaneous wave-free
ratio (iFR) measured at rest) was assessed.
Results: Before PCI, stenosis diameter was 6114%; FFR was 0.680.17 and iFR
was 0.730.23. Hyperemic ﬂow velocity rose signiﬁcantly after PCI (3020cm/s to
5125cm/s, p< 0.001). Anatomical parameters had a weak but signiﬁcant relation-
ship with the change in hyperemic ﬂow: diameter stenosis (R2 0.18, p¼0.0002) and
stenosis area (R2 0.11, p¼0.008). Physiological indices, in contrast, were strongly
predictive: iFR R2 0.51, p< 0.001, FFR R2 0.42, p< 0.001. For intermediate stenoses
(50-70% lesions), physiological parameters retained their stronger predictive value,
iFR R2 0.38, p< 0.001, FFR R2 0.35, p< 0.001, while the anatomical parameters had
little value (diameter stenosis R2 0.0015 p¼0.80; stenosis area R2 0.07 p¼0.16).
Conclusions: Both resting and hyperermic pressure-only physiological indices are
better than anatomical parameters in predicting the capacity of stenting to increaseR and Physiologic Lesion Assessment B95
